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Abstract
Sarcopenic muscular degeneration has been consistently identified as an independent risk
factor for mortality in aging populations. Recent investigations have realized the quantitative
potential of computed tomography (CT) image analysis to describe skeletal muscle volume
and composition; however, the optimum approach to assessing these data remains debated.
Current literature reports average Hounsfield unit (HU) values and/or segmented soft tissue
cross-sectional areas to investigate muscle quality. However, standardized methods for CT
analyses and their utility as a comorbidity index remain undefined, and no existing studies
compare these methods to the assessment of entire radiodensitometric distributions. The pri-
mary aim of this study was to present a comparison of nonlinear trimodal regression analysis
(NTRA) parameters of entire radiodensitometric muscle distributions against extant CT met-
rics and their correlation with lower extremity function (LEF) biometrics (normal/fast gait
speed, timed up-and-go, and isometric leg strength) and biochemical and nutritional parame-
ters, such as total solubilized cholesterol (SCHOL) and body mass index (BMI). Data were
obtained from 3,162 subjects, aged 66–96 years, from the population-based AGES-Reykjavik
Study. 1-D k-means clustering was employed to discretize each biometric and comorbidity
dataset into twelve subpopulations, in accordance with Sturges’ Formula for Class Selection.
Dataset linear regressions were performed against eleven NTRA distribution parameters and
standard CT analyses (fat/muscle cross-sectional area and average HU value). Parameters
from NTRA and CT standards were analogously assembled by age and sex. Analysis of spe-
cific NTRA parameters with standard CT results showed linear correlation coefficients greater
than 0.85, but multiple regression analysis of correlative NTRA parameters yielded a correla-
tion coefficient of 0.99 (P<0.005). These results highlight the specificities of each muscle qual-
ity metric to LEF biometrics, SCHOL, and BMI, and particularly highlight the value of the
connective tissue regime in this regard.
PLOS ONE | https://doi.org/10.1371/journal.pone.0193241 March 7, 2018 1 / 16
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Edmunds K, Gı´slason M, Sigurðsson S,
Guðnason V, Harris T, Carraro U, et al. (2018)
Advanced quantitative methods in correlating
sarcopenic muscle degeneration with lower
extremity function biometrics and comorbidities.
PLoS ONE 13(3): e0193241. https://doi.org/
10.1371/journal.pone.0193241
Editor: Masaki Mogi, Ehime University Graduate
School of Medicine, JAPAN
Received: August 22, 2017
Accepted: February 7, 2018
Published: March 7, 2018
Copyright: This is an open access article, free of all
copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or
otherwise used by anyone for any lawful purpose.
The work is made available under the Creative
Commons CC0 public domain dedication.
Data Availability Statement: The AGES-II dataset
cannot be made publicly available, since the
informed consent signed by the participants
prohibits data sharing on an individual level, as
outlined by the study approval by the Icelandic
National Bioethics Committee. Requests for these
data may be sent to the AGES-Reykjavik Study
Executive Committee, contact; MS Gudny
Eiriksdottir, gudny@hjarta.is.
Introduction
The progressive degeneration of aging muscle, known as Sarcopenia, has been consistently
identified as an independent risk factor for mortality [1–7], and while its prevalence has been
characterized by profound decreases in both physical activity and vitality, a normative quanti-
tative definition for its diagnosis and etiology remains debated around the world [8–10].
Nonetheless, extant clinical literature has interpreted its impact on physiological function and
cite Sarcopenia as the primary loss for muscle strength [11–13]. However, the degree to which
this loss of muscle strength may be attributed to the loss of muscle mass remains uncertain.
Current literature additionally cites the loss of muscle quality as a significant dictator for the
loss of muscle function–especially when in conjunction with a loss of muscle mass [14–16].
Nonetheless, methodological comparisons for the precise, non-invasive quantification of the
progressive reduction of muscle quality remain disparately described in literature. Standardiz-
ing a quantitative methodology for myological assessment in this regard would allow for the
generalizability of sarcopenia research to the indication of compensatory targets for clinical
intervention.
Skeletal muscle and aging
Aging skeletal muscle has a significantly reduced proportion of glycolytic type II muscle fibers
compared to young muscle, which in-turn directly elicits diminished myofibril contractility
[17, 18]. Additionally, aging skeletal myofibers significantly lack the ability to process triglycer-
ides, resulting in increased lipid droplet storage along myocyte cell membranes [19]. This
increased adiposity and decreased contractility has been linked to mitochondrial dysfunction
and impaired oxidative metabolism, which has been shown to secondarily induce metabolic
insulin resistance and Type 2 diabetes mellitus in patients [20, 21]. In general, non-contractile
tissue infiltration, in accordance with a loss of muscle mass, confers an increased risk for
frailty, disability, reduced mobility, and eventual hospitalization [22]. Indeed, a direct link
between aging and increasing degrees of non-contractile tissue infiltration in thigh muscle has
been observed [23, 24].
Studying how these changes affect mobility is the prime motive for lower extremity function
(LEF) research, which cites LEF as the main indicator for mobility as a clinical screening tool
[25]. LEF is generally assessed by measuring walking capacity (gait speed) and leg strength [26].
Altogether, the association of sarcopenic muscle degeneration with decreasing LEF illustrates
how aging induces mobility impairment, incident disability, and eventual mortality [27–30].
The role of imaging: Muscle quality as a clinical comorbidity index
Muscle biopsy is the standard clinical procedure used for the assessment of muscle, but the
procedure is invasive and occasionally limited in relevance by the small size of excised tissue.
However, recent investigations have realized the potential of X-ray computed Tomography
(CT) and Magnetic Resonance Imaging (MRI) to describe muscle quality and composition.
This is often performed either quasai-quantitatively, via the visual grading of muscle structure
morphologies [31–34], or quantitatively via the computation of muscle cross-sectional areas
and radiodensitometric absorption values in CT, measured in Hounsfield units (HU) [35–40].
Despite the superior soft tissue contrast in MRI and non-dependence on the use of ionizing
radiation, CT has higher spatial resolution and is comparatively less obfuscated by technical
variations in machine preparation and acquisition protocols [41, 42]. These notions are critical
when attempting to discern diagnostically-relevant information from cross-sectional images of
soft tissue.
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While the propensity of CT imaging literature describing sarcopenia differs largely regard-
ing analytical methodology, one metric that remains ubiquitous is the use of average HU val-
ues to characterize muscle quality. Goodpaster et al report the use of average HU values for
quantifying skeletal muscle lipid content, highlighting the potential for the method to investi-
gate the association between muscle composition and function [43–45]. Hicks et al likewise
utilized average HU values within lower back and posterior muscle groups to illustrate the
inverse relationship between these muscle qualities and the prevalence of lower back pain [46].
Additionally, Sur et al utilized average HU values weighted by total muscle area to show a cor-
relation between muscle quality in the psoas and serious post- Pancreaticoduodenectomy
complications [47]. Likewise, Lang et al utilized average HU attenuation values within thigh
muscles to predict the propensity for hip fracture in elderly, otherwise healthy subjects [48].
While average HU values might indeed describe general shifts in adiposity, generalizing CT
image matrices in this regard risks eliminating other distribution characteristics that could
explain additional subtle changes in muscle properties. We have previously shown the poten-
tial for computational modelling of entire radiodensitometric distributions using the novel
nonlinear trimodal regression analysis (NTRA) method [49]. The eleven unique regression
model parameters inherent to the NTRA method have shown utility in characterizing muscle
HU distributions in small cohorts, but using a large subject dataset to compare its utility to
those of current standard analyses (cross-sectional area and average HU value) has yet to be
reported. This was the prime motive for the present study, wherein CT cross-sections from the
midthighs of 3,162 community-dwelling subjects from ages 66–96 were assessed to correlate
upper leg muscle quality with continuous class LEF biometrics as well as biochemical and
nutritional parameters, such as total solubilized cholesterol (SCHOL) and body mass index
(BMI). The aim for this investigation was twofold: 1) to further develop an understanding of
quantitative muscle quality assessment as a potential subject-specific modeling tool, and 2) to
correlate NTRA parameters and parameters obtained using standard CT analyses with lower
extremity functions and biochemical parameters.
Materials and methods
Subject recruitment
The 3,162 volunteer subjects for this study were recruited from participants in the prospective
population-based five-year follow-up investigation of the Age Gene/Environment Susceptibil-
ity Study in Reykjavı´k, Iceland (AGESII-Reykjavik) [50–53]. The follow-up occurred from
2007–2011 and the percent of original subjects who participated was 71%. Written and
informed consent was obtained from all participants [50–53]. Ethical approval for patient data
acquisition was obtained by the Icelandic National Bioethics Committee, which serves as the
Institutional Review Board for the Icelandic Heart Association (RU Code of Ethics, cf. Para-
graph 3 in Article 2 of the Higher Education Institution Act no. 63/2006).
The follow-up group initially included 3,316 subjects whereof 3,169 participated in the
acquisition of CT scans of the mid-thigh. Seven additional subjects were excluded due to their
non-participation in biometric or comorbidity measurements. The remaining 3,162 subjects
(1,327 males, 1,835 females, mean age 79.9±4.8) participated in least one of the investigation’s
data measurements, and, out of this total investigation cohort, the percentage of participants
in each measurement ranged from 93.9% to 98.8%. Only those whose data mas acquired for
each metric were included into the present work.
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CT acquisition and segmentation
All participants in the project were scanned with a 4-row CT detector system at 120-kV (Sensa-
tion; Siemens Medical Systems, Erlangen, Germany) as previously described [50–53]. The
localized scanning region extended from the iliac crest to the knee joints. For each subject, a
single 10-mm thick transaxial mid-femur section was utilized in generating HU distributions
and calculating fat and muscle cross-sectional areas. Prior to the transaxial imaging, the correct
position for mid-femur imaging was determined by measuring the maximum length of the
femur on an anterior-posterior localizer image, followed by locating the center of the femoral
long axis.
Fat and muscle lean areas were segmented using the fascial plane outline between muscle
and subcutaneous fat as previously described [49]. A manual contouring program to draw the
contours of the total muscle bundle, and a threshold was chosen within each region to select
voxels with CT densities greater than the maximal density of fat, as documented [49, 51]. The
lean area of each muscle region was then calculated as the number of voxels above this thresh-
old, and lean tissue attenuation was defined as the mean CT density of these thresholded
voxels.
LEF biometrics and SCHOL/BMI measurements
LEF biometrics were assessed as part of the aforementioned AGES-Reykjavik Study. Continu-
ous-class measurements that were available for investigation included normal and fastest-com-
fortable gait speed (GSN and GSF, respectively), timed up-and-go (TUG), and isometric leg
strength (STR) [54]. Gait speeds were calculated in seconds over a distance of six meters, and
two trials were averaged for each subject according to published protocol [55]. The TUG test
measured the time taken to stand from a seated position, walk three meters, turn around, walk
back to the chair, and sit down; TUG is a well-reported screening metric for assessing balance
problems and daily activity declination [56]. Finally, STR was measured via knee extension
using an adjustable digital dynamometer on a fixed chair (Good Strength, Metitur, Palokka.
Finland). STR was measured at a fixed knee angle of 60 degrees from full extension, and the
subject’s ankle was fastened to a strain-gauge transducer. STR was measured by taking the
greater measured force of two knee extensions; each trial was four seconds in duration, with a
30 second rest between trials.
The SCHOL and BMI parameters from the AGES-Reykjavik study were included on the
basis of both their availability as age-related comorbidities and their being continuous-class in
nature. BMI was calculated as the subject’s weight (kilograms) divided by height (in meters)
squared, as previously reported [57]. Fasting total solubilized cholesterol levels were measured
via a Hitachi 912 with comparable enzymatic procedures (Roche Diagnostics, Mannheim, Ger-
many) [58]. All body weight and lipid measurements fulfilled the criteria of the National Insti-
tute of Health and the National Cholesterol Education Program for accuracy and precision.
Pixel distribution binning and smoothing
For each subject, HU distributions were derived from summing and transforming each pixel’s
CT number value according to the following linear transformation expression:
HU ¼ CT 2:26625   190 ð1Þ
Following transformation, HU values were binned into 128 bins, as typical for CT assess-
ment protocols [59]. Resultant histograms were smoothed by a non-parametric fitting
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algorithm to obtain underlying empirical probability density functions (PDF) for each histo-
gram. Each PDF was then exported for NTRA regression analyses.
Nonlinear trimodal regression analysis (NTRA) method
The method utilized to computationally define each HU distribution was a modified meth-
odology for nonlinear regression analysis. First, the general equation for each distribution
was defined as a quasi-probability density function by summing two skewed and one stan-
dard (α = 0) Gaussian distributions:
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where N is the amplitude, μ is the location, σ is the width, and α is the skewness of each dis-
tribution–all of which are iteratively evaluated at each CT bin, x. This definition is resultant
from the hypothesis that each HU distribution is trimodal, in that they consist of three sepa-
rate tissue types whose linear attenuation coefficients occupy distinct HU domains: namely,
fat (i = 1) [-200 to -10 HU], loose connective tissue and atrophic muscle (i = 2) [-9 to 40],
and normal muscle (i = 3) [41 to 200]. Additionally, we hypothesized that the inwardly-
sloping asymmetries within the fat and muscle peaks could be described by skewnesses of
their probability density functions, whereas the central connective tissue distribution was
assumed to be a normal, non-skewed Gaussian distribution. Utilizing this definition, a theo-
retical curve was generated by employing a iterative generalized reduced gradient algorithm
via minimization of the sum of standard errors at each CT bin value, x, thereby generating
an 11-parameter matrix of PDF variables. This algorithm iterates each function variable
according to the computed variance of each step, and the selection of new trial values is
guided by computing the rates of change of this variance as new inputs are generated. The
minimization of the sum of standard errors at each point, and thereby the maximization of
R2, was computed according to their standard definitions.
An illustration of the results of this concept is shown in Fig 1, where each of the three tissue
types and their respective PDFs have been depicted.
1-D K-means clustering discretization of LEF biometrics and SCHOL/BMI
With the modern adoption of electronic medical records (EMRs), the availability and breadth
of clinical data for use in medical research has markedly increased [60]. Commensurately,
there has been a rising interest in the development of novel algorithms from the fields of data
mining and machine learning for the processing of medical data [61, 62]. One of the common
preprocessing steps utilized prior to the employment of many of these algorithms is the discre-
tization of continuous variables. Discretization eliminates the necessity for presumptions
regarding distribution characteristics, as the method employs the counts within the dataset to
directly evaluate conditional probabilities [63].
For this reason, the present work identified the discretization of continuous class LEF bio-
metrics, SCHOL, and BMI as a strategic priority. Unsupervised methods for discretization
were initially selected, as they eliminate the requirement for class labels and can eventually be
utilized for multiple applications, unlike supervised discretization methods [63, 64]. After
investigation, the transformation of each continuous class variable was ultimately performed
using one-dimensional (1-D) k-means clustering [65]. In this method, each cluster-derived
bin had observations sorted using a medoid-partitioning algorithm [66]. The number of
groups (k) was calculated using Sturges’ formula for class selection, which implicitly bases bin
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sizes upon the range of the dataset, assuming a normal distribution of class values [63, 67]:
k ¼ log
2
nþ 1 ð3Þ
where the brackets denote the ceiling function, n is the dataset population, and k is the number
of bins. This yielded a k of twelve for each LEF and comorbidity parameter the study. Finally,
to assess the fidelity of linear relationships between muscle quality CT standards and NTRA
parameters, subjects were discretized by age and sex. Discretization was again unsupervised,
but this time by equal frequency due to the truncated nature of age, which is, in concept, a con-
tinuous class variable [68]. Using Sturges’ formula here resulted in 11.4 bins for men and 11.8
for women, so twelve bins were chosen for the sake of simplicity in assessing comparative lin-
ear regressions. This yielded bin populations of 111 for men, and 153 for women.
Fig 1. Diagram depicting the three components of the trimodal radiodensitometric distribution utilized in this study. This figure illustrates
the location and skewnesses of each PDF, with tissue types as follows: I) Fat [-200 to -10 HU], II) Water Equivalent and Loose Connective Tissue
[-9 to 40 HU], and III) Muscle [41 to 200 HU].
https://doi.org/10.1371/journal.pone.0193241.g001
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Statistical analyses
Linear regression models were utilized to statistically correlate the relationships of each inde-
pendent variable (LEF biometrics, SCHOL, and BMI) with respect to dependent variables
(NTRA parameters and standard CT analyses). Multiple regression models were then utilized
on assemblies of each dependent variable whose correlation coefficients described greater than
85% of the variance in each independent metric. One-way ANOVA and F-tests for overall sig-
nificance were compiled from each multiple regression model to illustrate statistically mean-
ingful correlation.
Results and discussion
Standard CT analyses on LEF biometrics and SCHOL/BMI
Fig 2 depicts the results from standard CT analyses on LEF biometrics, SCHOL, and BMI.
Each population bin is shown with colored circles ranging from the most unhealthy comorbid-
ity measurement or LEF value (red) to the healthiest group (green). Regression lines are like-
wise shown for each data series, along with their respective coefficients of determination (R2).
As is evident in Fig 2, the assessment of LEF biometrics, SCHOL, and BMI with current CT
standard methods yielded a host of physiologically evident results that are, to our knowledge,
presented in this manner for the first time. Firstly, fat cross-sectional areas held an inverse rela-
tionship with normal gait speeds, fast gait speeds, and isometric leg strengths, while conversely
showing positive correlation with timed up-and-go speeds (although while, in general, captur-
ing considerably less of the parameter variance: 0.80 and 0.77 for fat and muscle, respectively).
At the same time, muscle cross-sectional areas showed a directly inverse relationship with LEF
biometrics, compared to fat. Likewise, average HU values show commensurately expected
trends: the worse the LEF performance, the greater the shift in average soft tissue density
Fig 2. Current CT standard analyses against A) LEF biometrics and B) SCHOL and BMI. Note that each population bin is shown with colored circles ranging from the
unhealthiest (red) to the healthiest group (green), as defined by each parameter. Regression lines are likewise shown for each data series, along with their respective
coefficients of determination (R2).
https://doi.org/10.1371/journal.pone.0193241.g002
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towards fat (increasingly negative HU values). While these relationships are wholly explainable
in terms of muscle physiology, the apparent trends evidenced by SCHOL and BMI are more
intriguing: as any significant relationships without the removal of potentially-obfuscating, but
entirely relevant patient details might not have been expected. In this regard, it can be seen
how increasingly unhealthy BMI and SCHOL resulted in increasing fat areas and greater shifts
towards negative average HU values. With increasing BMI, both fat and muscle areas increased
together, although the rate of increase in fat was greater than the increase in muscle area. It is
apparent that most current standard metrics held linear regression coefficients of determina-
tion greater than 0.85, suggesting their general utility in capturing the population variance of
each metric.
NTRA analyses on LEF biometrics and SCHOL/BMI
As a complimentary analysis to standard CT methods, NTRA parameters were analogously
assembled. Figs 3 and 4 depict linear regressions of distribution amplitudes, locations, widths,
and skewnesses against LEF biometrics and SCHOL/BMI, respectively.
What is first apparent from Fig 3 is the great variance in specificity among coefficients of
determination. Many parameters yield strongly linear relationships on the order of or greater
than standard CT analyses (R2>0.85), while others yield minimal or no correlation. It may be
readily hypothesized that the amplitude parameter varies identically with cross-sectional area
against these metrics, assumptively suggesting a direct relationship to the overall quantity of
each soft tissue type. Indeed, this is readily apparent in fat and muscle amplitudes: increasing
fat amplitudes with decreasing LEF performance can be seen, along with an inverse muscle
amplitude relationship. What is clearly different is the inclusion of the loose connective/water
equivalent tissue regime, which according to these results seems less tied to quantity, and
instead more to overall tissue quality–with the clear exception of isometric leg strength yield-
ing a strong relationship with connective tissue amplitude. For instance, it is apparent here
how connective tissue locations clearly shift towards more negative HU values with decreasing
LEF performance. In the context of the aforementioned presence of myosteatosis in aging
muscle, the commensurate presence of fibrosis has been observed [69, 70], but its precise mea-
surement by standard CT metrics remains impossible. Pushing further into other medical
imaging modalities such as MRI or ultrasound, to a degree, severe tissue fibrosis is detectable
using traditional image processing modalities; however, as their employment methods are gen-
erally more tuned to detect and diagnose pathological hepatic fibrosis, they may not be opti-
mized for detecting the comparatively-minute changes associated with the onset of sarcopenia.
Indeed, the contribution of fibrosis to traditional metrics of muscle quality remains an essen-
tial target for further investigation; it is thereby enticing to observe how the inclusion of the
present loose connective/water equivalent tissue regime in NTRA analysis may serve as a direct
metric for fibrosis with further study.
It is likewise possible to hypothesize that the NTRA width parameter might be directly
related to the overall variation in pixel values for each tissue regime, as an increasing range of
HU values would simply imply an increasing Gaussian distribution width. However, these
data suggest that this parameter is minimally related to gait speed and isometric leg strength,
but is instead almost singularly tied to timed up-and-go duration, as decreasing width clearly
confers longer TUG times. In all LEF metrics, however, the same relationship is observed:
increasing fat width and decreasing muscle width confer decreasing LEF performance. This
could likewise be more related to notions of tissue quality, as myosteatosis would present itself
as an increase in partial volume effect from an increase in the relative proximity of inter- and
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intramuscular fat and lean muscle. However, why this may be singularly apparent in the fat
distribution remains unclear.
Fig 3. NTRA parameters against LEF biometrics. Each population bin is shown with colored circles ranging from the unhealthiest LEF value (red) to the healthiest group
(green). Regression lines and their corresponding R2 values are analogously shown for each data series.
https://doi.org/10.1371/journal.pone.0193241.g003
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In regards to the NTRA location parameter, as before, our results indicate that shifts in
these values are less related to muscle and fat, but highly connected to loose connective/water
equivalent tissue. The standard CT analogue, in the case of location values would be the aver-
age HU value. When comparing the linear relationships of these parameters, analogous shifts
towards increasingly negative values are seen, in accordance with decreasing LEF
performance.
Finally, the NTRA skewness parameter may again be potentially thought of as a direct
descriptor for muscle quality, as intermuscular adiposity may incur the migration of lean tissue
pixels towards the center of the overall distribution, resulting in an increasingly-skewed PDF
shape. Intriguingly, all LEF parameters present the same trend: increasing muscle skewness
and less-negative fat skewness values inversely correlate with LEF performance. However, this
dependency is more tied to muscle than fat–an explanation for which, again, remains unclear.
Finally, Fig 4 depicts linear relationships with NTRA parameters in accordance with
SCHOL and BMI values. Here, one can immediately note analogous dependencies, as com-
pared to LEF performance biometrics. Indeed, increasing fat amplitudes and decreasing
muscle amplitudes confer healthier measurements for BMI and SCHOL levels. Shift in con-
nective tissue location confer increasingly negative values, in conjunction with greater BMI
and higher SCHOL levels. Increasing fat widths and decreasing muscle widths analogously
indicate increasingly unhealthy measurements; intriguingly, higher SCHOL values were
seen with increasing connective widths.. Increases in muscle skewnesses and less-negative
fat skewnesses correlated with less healthy BMI and SCHOL values. To summarize these
results, Fig 5 depicts the specificities of each NTRA parameter, showing associated LEF bio-
metrics and SCHOL/BMI values whose linear regressions yielded coefficients of determina-
tion of at least 0.85.
Fig 4. NTRA parameters against SCHOL and BMI. Population bins are shown with colored circles ranging from the unhealthiest measurement (red) to the healthiest
group (green), along with their regression lines and R2 values.
https://doi.org/10.1371/journal.pone.0193241.g004
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Multiple regression analyses were performed on all standard CT analyses and NTRA
parameters with individual linear regression coefficients of determination over 0.85 for each
LEF and SCHOL/BMI metric. Results from these analyses produced multiple regression mod-
els involving each parameter, and all models yielded multiple correlation coefficients greater
than 0.99 with ANOVA and F-test results with P<0.005. These results indicate the high fidelity
of multivariate correlation and robust statistical significance when all highly-linear LEF bio-
metrics and SCHOL/BMI values are included. Additionally, such strong multivariate correla-
tion suggests, at the very least, that these NTRA parameters should be included alongside
extant standard methods for muscle quality quantification.
NTRA and standard CT analyses on age and sex
Fig 6 depicts the results from NTRA and standard CT analyses on age and sex.
As an additional investigation, NTRA parameters and standard CT metrics were assessed
for linear correlation with age, stratified by subject sex. Fig 6 illustrates these results. What is
immediately evident is that age and sex may be possible confounding factors in muscle quality
analysis. However, while the linear dependencies of NTRA and standard CT analysis metrics
are clear in some cases (analogously greater than 0.85), correlation coefficients are overall
much lower than those of LEF biometrics and SCHOL/BMI parameters. This altogether sug-
gests the necessity for correcting our model for age and sex, but likewise underscores the com-
parative ineffectuality of classic clinical assumptions of sarcopenic muscle degeneration based
on age and sex. Nonetheless, modeling muscle degeneration as shown without such correction
yet with high degrees of statistical significance is illuminating for further discussion, as being
able to predict changes in LEF biometrics and SCHOL/BMI values implicated in sarcopenia
regardless of age and sex may be of considerable inherent value.
Fig 5. Assembly of NTRA parameters with high correlation fidelity. Parameters were selected for yielding LEF and SCHOL/BMI correlation coefficients greater than
0.85.
https://doi.org/10.1371/journal.pone.0193241.g005
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Study strengths and limitations
As previously mentioned, partial volume effects can affect HU distributions, which can lead to
errors in parameter estimation, but such errors would be systematic throughout the whole
dataset and therefore not affect the overall results. The strength of this study is the large patient
cohort evaluated and the trends that show high correlation with the lower extremity functions
as well as the biochemical and nutritional parameters. However, since age and sex may be pos-
sible confounding factors in muscle quality analysis due to their occasionally-strong linear
dependencies on NTRA and standard CT analysis metrics. While this suggests the necessity
for model correction in this regard, age and sex correlation coefficients were much lower over-
all compared to those of LEF biometrics and SCHOL/BMI parameters. It would be a valuable
future step in the direction of this work to rigorously evaluate these potential dependencies.
Furthermore, as is true in any such study, the use of more subjects and aging comorbidities
will be essential to reinforcing any of the physiological interpretations reported here, and fur-
ther discussion regarding potential applications and adjustments to the reported model will be
requisite.
Conclusions
The present study illustrates the notion that rigorous quantification of entire HU distribu-
tions can elicit many unique assessment parameters and therein provide additional infor-
mation regarding muscle quality alongside extant current standard CT analysis methods.
Parameters obtained by the NTRA method demonstrated higher correlation with lower
Fig 6. NTRA and standard CT analyses against age and sex. Each age bin depicts the differences between male (blue) and female (red) subjects. A) Shows each NTRA
parameter against subject age for fat (circles) and muscle (squares). In addition, B) shows NTRA parameters associated with loose connective tissue, and C) shows
standard CT analyses. Regression lines and their respective coefficients of determination are depicted here for each data series.
https://doi.org/10.1371/journal.pone.0193241.g006
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extremity functions and biochemical variables than parameters obtained from standardized
CT analysis. These results highlight the methodological importance of including entire
radiodensitometric distributions in accordance with the NTRA assessment method and
provide further insight into how muscle degeneration in sarcopenia can be optimally diag-
nosed and quantified.
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